CompoAtlas

BRAIN BOOSTERS GINKGO BILOBA

Natural health product licensed in Canada

Other names
GINKGO BILOBA, MOLESCI & MATESCI GINKGO BILOBA, MOMALIFE BRAIN BOOSTER, MOMALIFE GINKGO BILOBA
Licence holder
Molesci & Matesci Inc.
NPN or DIN-HM
80062793
Status
Active licence
Licence date
16 July 2015
Revision date
Not provided
Form
Capsule
Route of administration
Orale
Application type
Officinale

If this product were sold in France

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the sourceMaximum per day, adult
Panax ginseng

Source : Racine

Extract : Matériel brut sec

Extraction ratio : 2.083:1

Dry plant equivalent : 93.75 milligramme

Potency : 24 % Ginsenoside Rg1

45 milligrammeNot calculated
Panax ginseng

Source : Racine

Potency : 24 % Ginsenoside Rb1

Not specifiedNot calculated
Ginkgo biloba

Source : Plante entière

Potency : 24 % Ginkgolide A

500 milligrammeNot calculated
Bacopa monnieri

Source : Fruit and leaf

100 milligrammeNot calculated

Non-medicinal ingredients

Stéarate de magnésium

PopulationAgeQuantity per servingFrequency
AdultesNot specified3 Capsule3 Tous les jours

Uses authorised in Canada

Helps to enhance cognitive function and/or improve memory in adults. Helps to support peripheral circulation.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Source

Official Health Canada record, licence 80062793

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line